Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Kv4.3/KChIP2/Ito complex is a voltage-gated potassium channel complex primarily responsible for the cardiac transient outward potassium current (Ito). It is composed of the Kv4.3 alpha subunit (encoded by the KCND3 gene) and the auxiliary subunit KChIP2. This complex plays a crucial role in regulating the early repolarization phase of the cardiac action potential, influencing heart rate and susceptibility to arrhythmias. Dysfunction or mutations in this complex are associated with cardiac disorders like Brugada syndrome and early repolarization pattern.
Channel blocker
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel subfamily D member 3 with KChIP2 coexpression complex (Kv4.3/KChIP2/Ito).